Diagnostic Value of Combinatorial Markers in Colorectal Carcinoma.

Blood-based tests have been shown to be an effective strategy for colorectal cancer (CRC) detection in screening programs. This study was aimed to test the performance of 20 blood markers including tumor antigens, inflammatory markers, and apolipoproteins as well as their combinations. In total 203 healthy volunteers and 102 patients with CRC were enrolled into the study.